Related Experiment Video
Updated: Jul 14, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
The impact of diabetes on heart failure: opportunities for intervention
Hadi N Skouri1, W H Wilson Tang
1Department of Cardiovascular Medicine, The Cleveland Clinic, 9500 Euclid Avenue, F25, Cleveland, OH 44195, USA.
Insights
Diabetes mellitus and heart failure share pathophysiologic processes, impacting heart function. While standard treatments are effective, current diabetes drugs pose safety risks, necessitating novel therapies.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Diabetes mellitus and heart failure exhibit interconnected pathophysiologic mechanisms.
- Hyperglycemia and insulin resistance contribute to cellular myocardial dysfunction.
- Comorbidities in diabetes and heart failure patients increase vulnerability.
Purpose of the Study:
- To explore the relationship between diabetes mellitus and heart failure.
- To assess the impact of diabetes on myocardial function.
- To review current treatment strategies and emerging therapies.
Main Methods:
- Literature review of pathophysiologic processes.
- Analysis of clinical outcomes in patients with both conditions.
- Evaluation of antidiabetic medication safety profiles.
Main Results:
- Diabetes-induced hyperglycemia and insulin resistance cause cellular myocardial abnormalities.
- Patients with both conditions often have comorbidities increasing risks.
- Standard heart failure regimens are generally effective, but antidiabetic drug safety is a concern.
Conclusions:
- Novel therapies targeting metabolic and structural changes in diabetes are under development.
- These emerging treatments may offer benefits beyond the diabetic population.
- Further research is needed to optimize treatment for patients with comorbid diabetes and heart failure.
Abstract:
The pathophysiologic processes of diabetes mellitus and heart failure are likely interrelated. In particular, hyperglycemia and insulin resistance can induce myocardial contractile systolic and diastolic abnormalities at the cellular level. Furthermore, patients with heart failure and concomitant diabetes mellitus are more likely to have underlying comorbid conditions resulting in greater vulnerability to adverse consequences. It is reassuring that the majority of patients with diabetes mellitus and heart failure respond to standard heart failure medical regimens comparable to their nondiabetes counterparts. However, the safety profiles of current antidiabetic medications are far from ideal when used in patients with heart failure. Emerging novel therapies that reverse the metabolic and structural changes induced by the diabetic milieu are currently under clinical development, and their potential benefits may even extend beyond the diabetic population.
Related Concept Videos
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation